Todd Longsworth joined Novocure in April 2012 and serves as General Counsel. Todd was previously Chief of Mergers & Acquisitions, Securities and Corporate Governance Counsel for Cephalon, Inc. Prior to joining Cephalon, he was an associate at WilmerHale LLP in Boston. Mr. Longsworth earned his B.A. from Duke University and his J.D. from the University of Pennsylvania.
clinical trialsOur mechanism of action is broadly applicable across a variety of solid tumors.
novocuretrial.comThe science of Tumor Treating Fields extends beyond glioblastoma. We are conducting clinical trials in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer and mesothelioma.